Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos)

Tsung-Han Tsai(Massachusetts Institute of Technology), Hiroshi Mashimo(VA Boston Healthcare System), Hsiang‐Chieh Lee(National Taiwan University), Chao Zhou(Washington University in St. Louis), James G. Fujimoto(IIT@MIT), Yuankai K. Tao(Massachusetts Institute of Technology), Qin Huang(People's Hospital of Xinjiang Uygur Autonomous Region), Joseph M. Schmitt(GlobalFoundries (United States)), Osman O. Ahsen(University of Massachusetts Boston), Desmond C. Adler(Massachusetts Institute of Technology), Marisa Figueiredo(VA Boston Healthcare System), Tejas Kirtane(Harvard University)
Gastrointestinal Endoscopy
July 24, 2012
10.1016/j.gie.2012.05.024
Cited by 62

Related Papers

Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Durability of Radiofrequency Ablation in Barrett's Esophagus With Dysplasia
|Gastroenterology|2011|455
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
|Journal of Biological Chemistry|1993|375